Facellitate
faCellitate GmbH, is developing and marketing interactive surface coatings for advanced cell technologies and regenerative medicine. faCellitate’s product offering currently encompasses three products that are a part of its BIOFLOAT™ product line: the BIOFLOAT™ 96-well plate, the BIOFLOAT™ 384-well plate and the BIOFLOAT™ FLEX coating solution for custom coating of cell culture lab ware. All BIOFLOAT™ products are based on a high-performance inert coating creating optimal conditions for the 3D culture of multicellular spheroids and organoids. For further information, please visit https://facellitate.com
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
12
11 to 50 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
2
tools in use
Monthly traffic
1.7K
organic / mo
Sign up free to see all 9 verified contacts at Facellitate
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- VF
Valentina Fermi
Head of Business Development · Sales & Business Development
EmailPhone - TS
Tanja Schollmeier
Customer Experience Manager · Customer/Client Service
EmailPhone - HG
Hasini Ganegala
Logistics Support and Scientific Content Writer · Other
EmailPhone - SA
Sarah al Muthafer
Principal Staff Scientist · Science
EmailPhone
Showing 4 of 9 verified contacts
Top roles at Facellitate
7 distinct titles indexed · top 7 shown.
- 1co-founder & managing director
- 1customer experience manager
- 1digital marketing analyst
- 1head of business development
- 1logistics support and scientific content writer
- 1principal staff scientist
- 1scientist
Sign up to unlock all 9 contacts at Facellitate
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Facellitate
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.